Rx Communications’ Post

Excited to speak on how AI will accelerate progress in pancreatic cancer treatment at Piedmont in Atlanta! We are one clinical trial away from individualizing care in pancreatic cancer- where one pre-treatment diagnostic test will guide complex, individualized combination therapy decisions based on genomics + CURE AI (Numenos AI).

Raising awareness about liver cancer is crucial as it remains a "silent killer," often progressing undetected until it's advanced. Siemens Healthineers is committed to equipping healthcare professionals with the technology needed for early diagnosis and effective treatment, supporting better outcomes for those affected. Get more in-depth information about liver cancer and care pathways: https://lnkd.in/ePbiS9AW   #livercancer #TeamHealthineers

What excites me most about the ESMO - European Society for Medical Oncology Congress isn’t just the science – it’s what the science can do for patients. This year, our team is sharing new data in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), demonstrating the broader potential of our investigational targeted therapy in hard-to-treat EGFR-driven diseases.    At Johnson & Johnson Innovative Medicine, we’re paving the way for new advancements in how we treat solid tumors. With every innovation, we’re taking a step toward transforming care and giving patients and families new reasons for hope.    As the conference wraps up, I’m encouraged by the future of cancer care and the role we will play in the fight against this disease: https://lnkd.in/dMjYWcEU     #MyCompany #JNJOncology #ESMO25 

October is Breast Cancer Awareness Month — and I’m honored to speak about one of the most important shifts in modern oncology: de-escalation in breast cancer care in Global Health Exhibition - ملتقى الصحة العالمي Rooted in precision oncology and value-based care, de-escalation is about right-sizing treatment — minimizing harm while preserving survival. It means using biology, risk stratification, and patient preferences to guide therapy rather than following a one-size-fits-all approach. This movement is a response to years of overtreatment in an era where diagnostics and systemic therapies have advanced dramatically. It also speaks to global equity — fewer surgeries, shorter radiation, and less chemotherapy translate into improved access, reduced toxicity, and better quality of life. At King Faisal Specialist Hospital and Research Center , we are actively implementing these strategies within our Cancer Center of Excellence, advancing integrated and personalized care pathways for every woman we treat. #BreastCancerAwareness #ValueBasedCare #PrecisionOncology #Deescalation #CancerCenterOfExcellence #KFSHRC #Vision2030

📣 New Lung Cancer Navigator/Coordinator Framework launched! This #LungCancerAwarenessMonth, LCNUK is delighted to launch a new Professional Development Framework for Lung Cancer Navigators/Coordinators. The framework supports Navigators, Coordinators, line managers, employers and policymakers by outlining the skills, knowledge and training required for this vital role. Ultimately, helping improve patient care and service delivery. 📘 Download the framework: https://ow.ly/6Boe50XnFbk “The lung cancer navigator or clinical care co-ordinator role is now a vital and established part of the team... Every team should have at least one navigator post, if not more!” — Jackie Fenemore, former LCNUK Chair (2019–2022) #LungCancerAwarenessMonth #LungCancerCare #Navigators

Breast cancer screening is more than just a scan, it’s a series of necessary steps designed to protect your health. From reviewing your medical history to checking for symptoms, Dr. Maria Ansari, Staff Physician in Medical Oncology at the Cancer Institute, and Dr. Zabair Ahmed, Staff Physician in Primary Care at the Medical Specialty Institute, explain how early detection of changes can make all the difference in getting timely treatment and better outcomes. Watch the full video through https://lnkd.in/dd8Abj4q

Immunotherapy Conversations Gain Momentum as Dr Tarang Krishna Reappears on NewsNowNation NewsNowNation revisits one of its most insightful health conversations as Dr Tarang Krishna, known for his work in integrative cancer care, returns to highlight the growing potential of immunotherapy in India. In his exclusive discussions with NewsNowNation in 2021 and again in 2025, Dr Krishna addressed a crucial concern: the intense fear associated with cancer and the urgent need to create awareness around newer, patient-centric treatment approaches. His interview explores how immunotherapy is reshaping cancer discussions globally, why early education matters, and how India can strengthen access to advanced treatment options. The session continues to gain traction among patients, medical professionals, and digital health communities. Watch the full interview and understand the shift in cancer care conversations. #NewsNowNation #HealthcareUpdate #Immunotherapy #CancerCare #MedicalAwareness #HealthInnovation #DigitalMedia #IndiaHealthNews #OncologyDiscussion https://lnkd.in/g-m-hshT

A new trial is shedding light on how a direct-to-patient digital health program, mPATH‑Lung, is making strides in lung cancer prevention. “Our study shows that reaching patients directly with digital tools can help overcome barriers to lung cancer screening and potentially save lives,” said David P. Miller, professor of implementation science in the Division of Public Health Sciences. “By empowering individuals with information and easy access to screening, we can make a real difference in early detection of lung cancer.” Learn more about the study, which recently published in JAMA: https://bit.ly/47zQr3J

Early detection is so crucial! mPATH-Lung is a direct-to-patient digital health program that can significantly increase lung cancer screening rates among people at high risk.

Excited to share that mPATH Health will be featured in an abstract being presented at the 2025 San Antonio Breast Cancer Symposium! The accepted late-breaking poster: "𝘋𝘪𝘨𝘪𝘵𝘢𝘭 𝘚𝘦𝘭𝘧 𝘚𝘦𝘳𝘷𝘪𝘤𝘦 𝘧𝘰𝘳 𝘉𝘳𝘦𝘢𝘴𝘵 𝘊𝘢𝘯𝘤𝘦𝘳 𝘚𝘤𝘳𝘦𝘦𝘯𝘪𝘯𝘨: 𝘌𝘢𝘳𝘭𝘺 𝘌𝘹𝘱𝘦𝘳𝘪𝘦𝘯𝘤𝘦 𝘸𝘪𝘵𝘩 𝘢 𝘋𝘪𝘳𝘦𝘤𝘵-𝘵𝘰-𝘗𝘢𝘵𝘪𝘦𝘯𝘵 𝘗𝘳𝘰𝘨𝘳𝘢𝘮 𝘪𝘯 𝘢 𝘍𝘦𝘥𝘦𝘳𝘢𝘭𝘭𝘺 𝘘𝘶𝘢𝘭𝘪𝘧𝘪𝘦𝘥 𝘏𝘦𝘢𝘭𝘵𝘩 𝘊𝘦𝘯𝘵𝘦𝘳," highlights the innovative work led by Kintegra Health & supported by Gilead Sciences’ FOCUS Breast Cancer Pilot Initiative. 𝗜𝗳 𝘆𝗼𝘂 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗮𝘁 #𝗦𝗔𝗕𝗖𝗦𝟮𝟬𝟮𝟱, 𝗰𝗼𝗺𝗲 𝗳𝗶𝗻𝗱 𝘁𝗵𝗲 𝗽𝗼𝘀𝘁𝗲𝗿 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝟬, 𝟮𝟬𝟮𝟱, 𝟭𝟮:𝟯𝟬 𝗣𝗠 - 𝟮:𝟬𝟬 𝗣𝗠! Gilead Sciences’ FOCUS Breast Cancer Pilot is a public health initiative that seeks to enable routine screening & linkage for breast cancer in accordance with public health guidelines to advance timely diagnoses. 🤝 This collaboration is making it easier for patients to access timely breast cancer screening & pre-treatment linkage, advancing public health in communities that need it most. 𝗚𝗿𝗮𝘁𝗲𝗳𝘂𝗹 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘃𝗶𝘀𝗶𝗼𝗻𝗮𝗿𝘆 𝗹𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗮𝘁 𝗞𝗶𝗻𝘁𝗲𝗴𝗿𝗮 𝗮𝗻𝗱 𝘁𝗵𝗲 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗿𝗼𝗺 Gilead Sciences. #BreastCancerAwareness #ScreeningEarlySavesLives #SABCS2025 #DigitalHealth #HealthTechnology #CancerScreening #HealthEquity #KintegraHealth #GileadSciences #PublicHealthInnovation